L Rydén
Impact in
-
- Acute Myocardial Infarction Research
- Cardiac electrophysiology and arrhythmias
- Blood Pressure and Hypertension Studies
- Cardiac Health and Mental Health
- Heart rate and cardiovascular health
- Heart Failure Treatment and Management
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
-
- Acute Myocardial Infarction Research 4
- Cardiac Arrhythmias and Treatments 3
- Cardiac electrophysiology and arrhythmias 3
- Cardiac pacing and defibrillation studies 2
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 5
- Diabetes Treatment and Management 3
- Co-authors
- Anders P. Waldenström (4 shared papers)Åke C. Hjalmarson (4 shared papers)Johan D. Herlitz (3 shared papers)Karl B Swedberg (3 shared papers)Finn Waagstein (3 shared papers)ANDERS VEDIN (2 shared papers)Claes Wilhelmsson (2 shared papers)Hans Wedel (2 shared papers)
- Journals
- Heart (3 papers)Journal of the American College of Cardiology (2 papers)European Heart Journal (2 papers)The Lancet (1 paper)New England Journal of Medicine (1 paper)
- Partner nations
- SwedenUnited StatesNetherlands
In The Last Decade
L Rydén
22 papers receiving 1.6k citations
L Rydén's Hit Papers
Peers
Comparison fields: 5 of 84
- Cardiology and Cardiovascular Medicine 1.2k
- Endocrinology, Diabetes and Metabolism 180
- Surgery 262
- Family Practice 14
- Pathology and Forensic Medicine 92
Countries citing papers authored by L Rydén
This map shows the geographic impact of L Rydén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Rydén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Rydén more than expected).
Fields of papers citing papers by L Rydén
This network shows the impact of papers produced by L Rydén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Rydén. The network helps show where L Rydén may publish in the future.
Co-authors
The 25 scholars most cited alongside L Rydén, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTION Hit paper breakdown → | 1981 | 868 |
| 2 | 'European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)' The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). [Eur Heart J 2012;33:1635-1701, doi: 10.1093/eurheartj/ehs092] Hit paper breakdown → | 2012 | 330 |
| 3 | 1983 | 237 | |
| 4 | 2006 | 108 | |
| 5 | 2008 | 78 | |
| 6 | 2020 | 54 | |
| 7 | 2007 | 46 | |
| 8 | 2000 | 31 | |
| 9 | 1983 | 26 | |
| 10 | [InlineMediaObject not available: see fulltext.]European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) - The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by Representatives of Nine Societies and by Invited Experts) | 2012 | 26 |
| 11 | Göteborg Metoprolol Trial: effects on arrhythmias. | 1984 | 25 |
| 12 | 1975 | 19 | |
| 13 | 1974 | 11 | |
| 14 | 1972 | 10 | |
| 15 | Overestimation of myocardial infarct size by histologic measurement in a model of occlusion followed by reperfusion. | 1990 | 6 |
| 16 | 1996 | 3 | |
| 17 | 1996 | 2 | |
| 18 | Chronobiologic analysis of ambulatory heart rate and blood pressure data from an implanted hemodynamic analyzer | 1998 | 2 |
| 19 | Proceedings: Effect of therapeutic doses of lignocaine hydrochloride on effective refractory period of right ventricle in humans. | 1976 | 1 |
| 20 | [The Swedish pacemaker registry is a source of patient safety]. | 1991 | 1 |
About L Rydén
L Rydén is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Public Health, Environmental and Occupational Health, Endocrine and Autonomic Systems and Microbiology, having authored 22 papers that have together received 1.9k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Acute Myocardial Infarction Research (4 papers), Cardiac Arrhythmias and Treatments (3 papers), Diabetes Treatment and Management (3 papers), Health Promotion and Cardiovascular Prevention (3 papers), Cardiac electrophysiology and arrhythmias (3 papers), Cardiac pacing and defibrillation studies (2 papers) and Clinical practice guidelines implementation (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.2k citations), Endocrinology, Diabetes and Metabolism (180 citations), Surgery (262 citations), Family Practice (14 citations) and Pathology and Forensic Medicine (92 citations). L Rydén has collaborated with scholars based in Sweden, United States and Netherlands. Frequent co-authors include Anders P. Waldenström, Åke C. Hjalmarson, Johan D. Herlitz, Karl B Swedberg, Finn Waagstein, ANDERS VEDIN, Claes Wilhelmsson, Hans Wedel, Stig Holmberg and G. Nyberg. Their work appears in journals such as Heart, Journal of the American College of Cardiology, European Heart Journal, The Lancet and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.